ELOXX PHARMACEUTICALS, INC.
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY1999 | — | — | $-1.2M |
| FY2000 | — | — | $-3.3M |
| FY2001 | — | — | $-2.0M |
| FY2002 | — | — | $-3.0M |
| FY2003 | — | — | $-2.8M |
| FY2004 | — | — | $-3.7M |
| FY2005 | — | — | $-3.0M |
| FY2006 | — | — | $-3.3M |
| FY2007 | — | — | $-3.3M |
| FY2008 | — | — | $-4.6M |
| FY2009 | — | — | $-5.7M |
| FY2010 | $140.0K | $-4.8M | $-13.4M |
| FY2011 | — | $-7.9M | $-7.3M |
| FY2012 | $200.0K | $-5.4M | $-5.1M |
| FY2013 | $7.8K | $-4.7M | $-6.1M |
| FY2014 | $182.2K | $-9.1M | $-9.2M |
| FY2015 | — | $-18.1M | $-18.1M |
| FY2016 | — | $-11.2M | $-8.3M |
| FY2017 | — | $-4.6M | $-5.8M |
| FY2018 | — | $-47.6M | $-47.2M |
| FY2019 | — | $-50.6M | $-50.9M |
| FY2020 | — | $-33.5M | $-34.6M |
| FY2021 | — | $-66.0M | $-66.7M |
| FY2022 | — | $-34.4M | $-36.1M |
| FY2023 | $0 | $-17.3M | $-17.1M |
| FY2024 | $6.4M | $-2.5M | $-3.1M |
| FY2025 | $0 | $-6.4M | $-6.0M |